Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OSI-906 and Sorafenib in Advanced Hepatocellular Cancer
NCT01334710Phase 2Terminated
- Sponsor
- Emory University
- Start
- Mar 2011
- Primary completion
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of linsitinib in hepatocellular carcinoma (HCC), sponsored by Emory University. Started Mar 2011; status: terminated.
02
Drugs
linsitinib
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT01334710.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01334710.